Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Anavex Successfully Closes $10 Million Financing to Initiate Phase 1b/2a Alzheimer's Clinical Trial
-
Notable Analyst Rating Changes 03/18: (HPQ) (VNET) (QGEN) Upgraded; (CSCO) (SINA) (EJ) Downgraded
-
Cesca Therapeutics to Present at Regen Med Investor Day March 26 in New York
-
Maxim Group Downgrades SINA Corporation (SINA) to Hold Post Weibo IPO
-
Inovio Pharmaceuticals (INO) Price Target Lifted to $6 at Maxim Group
-
Medivation (MDVN) Target Lifted at Maxim Group
-
Notable Analyst Rating Changes 03/14: (TEVA) (SIRI) (LOW) Upgraded; (PLUG) (XOXO) (NUE) Downgraded
-
Pre-Open Stock Movers 3/14: (HART) (MEET) (LMCA) Higher; (ARO) (ZBB) (PLUG) Lower (more...)
-
UPDATE: Maxim Group Sees Big Opportunity in Harvard Apparatus (HART), Starts at Buy w/PT of $19
-
Omeros (OMER) Prices 3.04M Common Offering at $11.50/Share
-
Galmed Pharmaceuticals (GLMD) IPO Opens Higher, Trends Lower
-
Maxim Group Upgrades PowerSecure (POWR) to Buy
-
StemCells, Inc. to Participate at 2014 Regen Med Investor Day in New York
-
Athersys to Present at Regen Med Investor Day March 26th in New York
-
BioLineRx (BLRX) Closes 9.66M ADS Offering for Gross Proceeds of $24.1M
-
Qihoo 360 (QIHU) Target Lifted to $130 at Maxim Group
-
Gilead Sciences (GILD) Bullish Stance Maintained at Maxim Group
-
Maxim Group Starts Energen (EGN) at Buy
-
Maxim Group Starts Paragon Shipping Inc. (PRGN) at Buy
-
Inovio Pharma (INO) Closes 21.8M Common Stock Offering
-
BioLineRx (BLRX) Prices 8.4M Offering at $2.50/ADS
-
BioLineRx (BLRX) Lower on Stock Offering
-
Dendreon (DNDN) Posts a Solid Quarter - Maxim Group
-
Magic Software (MGIC) Prices 6M Offering at $8.50/Share
-
Magic Software Enterprises Ltd. (MGIC) Announces Offering
-
Maxim Group Maintains Bullish View on Baidu (BIDU) Post Q4
-
Notable Analyst Rating Changes 02/26: (LNKD) (RRC) (ARIA) Upgraded; (PSA) (NIHD) (HUM) Downgraded
-
Maxim Group Upgrades ARIAD Pharmaceuticals (ARIA) to Buy
-
Vertex (VRTX) Target Lifted to $92 at Maxim Group
-
Tekmira Pharma (TKMR) Jumps as Maxim Group Nearly Doubles Price Target
-
Maxim Group Starts Oxford Lane (OXLC) at Buy
-
Notable Analyst Rating Changes 02/19: (FLR) (ACT) (CPST) Upgraded; (YOKU) (SCTY) (NPSP) Downgraded
-
Pre-Open Stock Movers 2/19: (ZLC) (CHTP) (GRMN) Higher; (SM) (GNK) (LZB) Lower (more...)
-
UPDATE: Maxim Group Downgrades Youku Tudou (YOKU) to Sell on Intensified Competition
-
Notable Analyst Rating Changes 02/12: (CROX) (S) (ZTS) Upgraded; (AMZN) (DF) (GMCR) Downgraded
-
Pre-Open Stock Movers 2/12: (OC) (CSTE) (TRIP) Higher; (VTUS) (RLOC) (PRGN) Lower (more...)
-
Paragon Shipping (PRGN) Prices 5.9M Common Offering at $6.25/Share
-
Maxim Group Downgrades Williams Companies (WMB) to Hold
-
After-Hours Stock Movers 2/11: (MRIN) (CUTR) (PHH) Higher; (PRGN) (FEYE) (CSOD) Lower (more...)
-
Paragon Shipping (PRGN) to Offer Common Stock
-
Maxim Group Upgrades Navios Maritime Acquisition Corp. (NNA) to Buy
-
Maxim Group Upgrades Allscripts (MDRX) to Buy
-
Michael Kors (KORS) Target Priced Lifted to $109 at Maxim Group on Strong Q3
-
Streetinsider.com's Hot Lunchtime Reads 02/05: (GILD) (DDD) (OMER) (BBRY)
-
Omeros (OMER) Pipeline Progress Looks Good to Maxim Group
-
Gilead Sciences (GILD) Target Lifted to $101 at Maxim Group
-
Gross Margin Rate Will Drive Michael Kors (KORS) Upon Results, Maxim Group Says
-
Orchid Island Capital Announces Closing of Sale of Shares Pursuant to Full Exercise of Underwriters' Overallotment Option
-
Streetinsider.com's Hot Lunchtime Reads 01/29: (YRCW) (HLF) (NFLX) (VMEM)
-
Vringo (VRNG) Target Price Lifted to $7 at Maxim Group

